DexCom Profile



Odds of Distress

Check how we calculate scores
Equity ratings for DexCom are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting June 17, 2019 and ending today September 15, 2019. Click here to learn more.
USD 0.9  0.62%

DexCom Summary

DexCom (DXCM) is traded on BATS Exchange in USA. It is located in 6340 Sequence Drive and employs 2,800 people. DexCom is listed under Medical Equipment category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with current market capitalization of 14.16B. DexCom conducts business under Healthcare sector and is part of Diagnostics & Research industry. The entity has 91.19M outstanding shares of which 6.04M shares are currently shorted by private and institutional investors with about 6.8 trading days to cover. DEXCOM currently holds about 1.38B in cash with (143.4M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 15.11.
Check DexCom Probability Of Bankruptcy

Ownership Allocation (%)

DexCom Target Price Odds Analysis

Odds Below 145.36HorizonTargetOdds Above 145.36
52.04%30 days 145.36 47.88%
Based on normal probability distribution, the odds of DexCom to move above current price in 30 days from now is about 47.88% (This DexCom probability density function shows the probability of DexCom Stock to fall within a particular range of prices over 30 days) .

DexCom Top Holders

DexCom Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Vanguard Group IncCommon Shares8.2 M1.2 B
Fmr LlcCommon Shares6.3 M947.7 M
View DexCom Diagnostics

DexCom Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

DexCom Key Fundamentals

DexCom Against Markets

DexCom Vital Trading Data

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California. DexCom operates under Diagnostics Research classification in USA and is traded on BATS Exchange. It employs 2800 people. more
Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
DexCom SEC Filings
DexCom SEC Filings
Security & Exchange Commission EDGAR ReportsView All
CEO and President and DirectorKevin SayerView All
Thematic Classification
Currently Active Investing Idea
  Medical Equipment
View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Healthcare, Diagnostics & Research
InstrumentUSA Stock View All
RegionNorth America
LocationCalifornia U.S.A
Business Address6340 Sequence Drive
ExchangeBATS Exchange
CIK Number0001093557
IndustryDiagnostics & Research
Phone858 200 0200
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterJune 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestAugust 15, 2019

DexCom Corporate Directors

Eric Topol Independent Director
Nicholas Augustinos Independent Director
Mark Foletta Independent Director
Additionally see Investing Opportunities. Please also try Portfolio Manager module to state of the art portfolio manager to monitor and improve performance of your invested capital.